BMPR-IB Activators, also known as Bone Morphogenetic Protein Receptor Type IB Activators, belong to a class of chemical compounds that specifically target and modulate the activity of the BMPR-IB receptor. These receptors are integral components of the Bone Morphogenetic Protein (BMP) signaling pathway, which plays a crucial role in various cellular processes, including embryonic development, tissue regeneration, and bone homeostasis. BMPR-IB is a transmembrane serine/threonine kinase receptor that interacts with BMP ligands to initiate intracellular signaling cascades. BMP ligands bind to BMPR-IB, leading to the activation of downstream signaling molecules such as Smad proteins, which ultimately regulate gene expression.
The chemical class of BMPR-IB Activators is characterized by compounds that enhance or modulate the activation of BMPR-IB receptors, either by promoting ligand-receptor interactions or by influencing the downstream signaling events. These compounds can serve as valuable tools in research settings to dissect the intricate roles of BMP signaling in various physiological and pathological contexts. Researchers often use BMPR-IB Activators to study the developmental processes associated with bone and cartilage formation, as well as to investigate the molecular mechanisms underlying tissue regeneration and repair. Additionally, the ability to manipulate BMPR-IB activity can shed light on its involvement in conditions such as osteoporosis and osteoarthritis, providing insights into research on these disorders. Overall, BMPR-IB Activators are essential components in the toolkit of scientists seeking to unravel the complexities of BMP signaling and its implications in diverse biological processes.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
13-cis-Retinoic acid | 4759-48-2 | sc-205568 sc-205568A | 100 mg 250 mg | $75.00 $120.00 | 8 | |
13-cis-Retinoic acid impacts cellular differentiation and might affect BMPR-IB expression due to its influence on cellular retinoic acid levels. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, leading to an increase in cAMP, which can modulate a range of signaling pathways, potentially including those that regulate BMPR-IB expression. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein, a phytoestrogen, can modulate various signaling pathways including estrogen receptor signaling, which may indirectly influence BMPR-IB expression. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
As a cAMP analog, Dibutyryl-cAMP can penetrate cell membranes and activate cAMP-dependent pathways, potentially enhancing BMPR-IB expression. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate is a histone deacetylase inhibitor that can lead to chromatin remodeling and potentially upregulate BMPR-IB expression by influencing gene accessibility. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is another histone deacetylase inhibitor, which may upregulate BMPR-IB expression through epigenetic modulation of gene expression. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of MEK, which is a part of the MAPK/ERK pathway; altering this pathway might influence BMPR-IB expression levels. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, and by affecting the PI3K/Akt pathway, it may have downstream effects on BMPR-IB expression. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB431542 is an inhibitor of the TGF-β type I receptor ALK5, which may affect BMP signaling pathways, including the regulation of BMPR-IB. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, a key regulator of cell growth and proliferation, which might also affect BMPR-IB expression indirectly. | ||||||